SocietyWestern drugmakers spend up to $500 million a year on bribes in Russia, Proekt investigation finds
Foreign pharmaceutical companies supplying cancer drugs to Russia pay about $500 million a year in bonuses to intermediaries, suppliers and hospital staff, according to Proekt. The investigation says much of the money funds bribes and that people connected to the Russian government benefit. In 2025, Russia bought 386.3 billion rubles’ worth of drugs from eight major foreign firms; a source said prices could be 15–25% lower without corruption.
Western drugmakers spend up to $500 million a year on bribes in Russia, Proekt investigation finds